Supriya Lifescience Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the production of active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a strong focus on quality and innovation, Supriya Lifescience offers a diverse range of products, including anti-allergic, anti-inflammatory, and anti-viral APIs. Their commitment to research and development has led to significant advancements, positioning them as a trusted supplier in the global pharmaceutical landscape. Notably, the company has achieved several milestones, including regulatory approvals from major international health authorities, further solidifying its reputation for excellence in the industry.
How does Supriya Lifescience Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Supriya Lifescience Limited's score of 28 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Supriya Lifescience Limited reported total carbon emissions of approximately 4,451,010 kg CO2e for Scope 1 and 10,995,310 kg CO2e for Scope 2. This marks a slight decrease in Scope 1 emissions from 490,206 kg CO2e in 2023 and 315,257 kg CO2e in 2022, while Scope 2 emissions decreased from 11,450,770 kg CO2e in 2023 and 8,643,810 kg CO2e in 2022. The company has not disclosed any Scope 3 emissions data, indicating a focus on direct and indirect emissions from its operations and energy use. Despite the absence of specific reduction targets or commitments, Supriya Lifescience Limited is actively monitoring its emissions and has reported emissions intensity metrics, which reflect its performance relative to revenue. Overall, while Supriya Lifescience Limited has not set formal reduction targets or climate pledges, it continues to track and report its emissions, demonstrating a commitment to transparency in its environmental impact.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | 2024 | |
---|---|---|---|
Scope 1 | 315,257 | 000,000 | 000,000 |
Scope 2 | 8,643,810 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Supriya Lifescience Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.